BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 14745861)

  • 1. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
    Blakely LJ; Buzdar AU; Lozada JA; Shullaih SA; Hoy E; Smith TL; Hortobagyi GN
    Cancer; 2004 Feb; 100(3):465-9. PubMed ID: 14745861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
    Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
    Harris EE; Hwang WT; Seyednejad F; Solin LJ
    Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.
    Shen J; Hunt KK; Mirza NQ; Krishnamurthy S; Singletary SE; Kuerer HM; Meric-Bernstam F; Feig B; Ross MI; Ames FC; Babiera GV
    Cancer; 2004 Sep; 101(6):1330-7. PubMed ID: 15316905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
    Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
    Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
    Galper S; Blood E; Gelman R; Abner A; Recht A; Kohli A; Wong JS; Smith D; Bellon J; Connolly J; Schnitt S; Winer E; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):348-57. PubMed ID: 15667952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of breast carcinoma in the elderly: implications for screening and treatment.
    Singh R; Hellman S; Heimann R
    Cancer; 2004 May; 100(9):1807-13. PubMed ID: 15112260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
    Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?
    Vicini FA; Kestin L; Huang R; Martinez A
    Cancer; 2003 Feb; 97(4):910-9. PubMed ID: 12569590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.
    Montero AJ; Rouzier R; Lluch A; Theriault RL; Buzdar AU; Delaloge S; Bermejo B; Le M; Kau SW; Dunant A; Arriagada R; Spielmann M; Garcia-Conde J; Sahin AA; Singletary SE; Hortobagyi GN; Valero V
    Cancer; 2005 Jul; 104(2):229-35. PubMed ID: 15937910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
    Esteva FJ; Sahin AA; Smith TL; Yang Y; Pusztai L; Nahta R; Buchholz TA; Buzdar AU; Hortobagyi GN; Bacus SS
    Cancer; 2004 Feb; 100(3):499-506. PubMed ID: 14745865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
    Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
    Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and prognostic factors of postoperative chemotherapy for female breast cancer patients under 30 years of age: a report of 129 patients].
    Wang ZH; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):111-3. PubMed ID: 15946553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.